Keen Nicholas
CHIEF SCIENTIFIC OFFICER at BCYC
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jul 3, 2024
- Form 144 notices
- 6
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- BCYCBICYCLE THERAPEUTICS PLCCHIEF SCIENTIFIC OFFICER
Sales by reason
0
Routine
2
Plan not stated
5
No plan
6
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Oct 3, 2024Notice
Filed a notice to sell 308 shares
$7k308 shares
- Jul 3, 2024No plan
Sold 1.2% of their holdings
$15k779 shares at $19.64
- Jul 3, 2024Notice
Filed a notice to sell 779 shares
$15k779 shares
- Apr 3, 2024No plan
Sold 1.2% of their holdings
$19k790 shares at $23.81
- Apr 3, 2024Notice
Filed a notice to sell 790 shares
$19k790 shares
- Jan 3, 2024Unusual
Sold 4% of their holdings
$46k2,640 shares at $17.50
- Jan 3, 2024Notice
Filed a notice to sell 2,640 shares
$49k2,640 shares
- Oct 3, 2023No plan
Sold 0.7% of their holdings
$5k272 shares at $20.00
- Oct 3, 2023Notice
Filed a notice to sell 272 shares
$5k272 shares
- Jul 3, 2023No plan
Sold 0.9% of their holdings
$8k336 shares at $25.10
10 of 19
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Jul 8, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Sold | 779 | $19.64 | $15k | 62,024 | SEC |
| Apr 3, 2024 | Apr 5, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Sold | 790 | $23.81 | $19k | 62,803 | SEC |
| Jan 3, 2024 | Jan 4, 2024 | BCYC | Chief Scientific Officer | Sold | 2,640 | $17.50 | $46k | 63,593 | SEC |
| Jan 2, 2024 | Jan 4, 2024 | BCYC | Chief Scientific Officer | AwardedEmployee Stock Option (right to buy) | 56,000 | 56,000 | SEC | ||
| Jan 2, 2024 | Jan 4, 2024 | BCYC | Chief Scientific Officer | Awarded | 28,000 | 66,233 | SEC | ||
| Oct 3, 2023 | Oct 5, 2023 | BCYC | Chief Scientific Officer | Sold | 272 | $20.00 | $5k | 38,233 | SEC |
| Jul 3, 2023 | Jul 6, 2023 | BCYC | Chief Scientific Officer | Sold | 336 | $25.10 | $8k | 38,505 | SEC |
| Apr 3, 2023 | Apr 5, 2023 | BCYC | Chief Scientific Officer | Sold | 319 | $21.11 | $7k | 38,841 | SEC |
| Jan 3, 2023 | Jan 5, 2023 | BCYC | Chief Scientific Officer | Sold | 1,817 | $29.06 | $53k | 39,160 | SEC |
| Jan 3, 2023 | Jan 5, 2023 | BCYC | Chief Scientific Officer | AwardedEmployee Stock Option (right to buy) | 35,000 | 35,000 | SEC | ||
| Jan 3, 2023 | Jan 5, 2023 | BCYC | Chief Scientific Officer | Awarded | 17,500 | 40,977 | SEC | ||
| Jan 3, 2022 | Jan 5, 2022 | BCYC | Chief Scientific Officer | AwardedEmployee Stock Option (right to buy) | 30,000 | 30,000 | SEC | ||
| Jan 3, 2022 | Jan 5, 2022 | BCYC | Chief Scientific Officer | Awarded | 15,000 | 23,477 | SEC | ||
| Dec 21, 2021 | Dec 22, 2021 | BCYC | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 15,477 | 161,927 | SEC | ||
| Dec 21, 2021 | Dec 22, 2021 | BCYC | Chief Scientific Officer | Exercised options | 15,477 | $14.00 | $217k | 15,477 | SEC |
| Oct 5, 2021 | Oct 5, 2021 | BCYC | Chief Scientific Officer | Sold | 3,366 | $45.06 | $152k | 0 | SEC |
| Sep 16, 2021 | Sep 17, 2021 | BCYC | Chief Scientific Officer | Sold | 4,955 | $45.00 | $223k | 3,366 | SEC |
| Sep 2, 2021 | Sep 3, 2021 | BCYC | Chief Scientific Officer | Sold | 10,000 | $40.00 | $400k | 8,321 | SEC |
| Jul 14, 2021 | Jul 16, 2021 | BCYC | Chief Scientific Officer | Sold | 10,000 | $35.00 | $350k | 18,321 | SEC |
| Mar 31, 2021 | Apr 2, 2021 | BCYC | Chief Scientific Officer | Sold | 10,000 | $30.00 | $300k | 28,321 | SEC |
| Mar 15, 2021 | Mar 16, 2021 | BCYC | Chief Scientific Officer | Sold | 10,000 | $28.48 | $285k | 38,321 | SEC |
| Jan 4, 2021 | Jan 5, 2021 | BCYC | Chief Scientific Officer | AwardedEmployee Stock Option (right to buy) | 70,500 | 70,500 | SEC | ||
| Jan 2, 2020 | Jan 6, 2020 | BCYC | Chief Scientific Officer | AwardedEmployee Stock Option (right to buy) | 60,000 | 60,000 | SEC | ||
| May 28, 2019 | May 30, 2019 | BCYC | Chief Scientific Officer | AwardedStock Option (Right to Buy) | 177,404 | 177,404 | SEC |
Sales and notices (19)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2024 | Oct 3, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 308 | $7k | Notice | SEC | |
| Jul 3, 2024 | Jul 8, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 779 | $15k | 1.2% | No plan | SEC |
| Jul 3, 2024 | Jul 3, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 779 | $15k | Notice | SEC | |
| Apr 3, 2024 | Apr 5, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 790 | $19k | 1.2% | No plan | SEC |
| Apr 3, 2024 | Apr 3, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 790 | $19k | Notice | SEC | |
| Jan 3, 2024 | Jan 4, 2024 | BCYC | Chief Scientific Officer | Form 4 sale | 2,640 | $46k | 4.0% | Unusual | SEC |
| Jan 3, 2024 | Jan 3, 2024 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 2,640 | $49k | Notice | SEC | |
| Oct 3, 2023 | Oct 5, 2023 | BCYC | Chief Scientific Officer | Form 4 sale | 272 | $5k | 0.7% | No plan | SEC |
| Oct 3, 2023 | Oct 3, 2023 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 272 | $5k | Notice | SEC | |
| Jul 3, 2023 | Jul 6, 2023 | BCYC | Chief Scientific Officer | Form 4 sale | 336 | $8k | 0.9% | No plan | SEC |
| Jul 3, 2023 | Jul 3, 2023 | BCYC | CHIEF SCIENTIFIC OFFICER | Form 144 notice | 336 | $8k | Notice | SEC | |
| Apr 3, 2023 | Apr 5, 2023 | BCYC | Chief Scientific Officer | Form 4 sale | 319 | $7k | 0.8% | No plan | SEC |
| Jan 3, 2023 | Jan 5, 2023 | BCYC | Chief Scientific Officer | Form 4 sale | 1,817 | $53k | 4.4% | Plan not stated | SEC |
| Oct 5, 2021 | Oct 5, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 3,366 | $152k | 100.0% | Unusual | SEC |
| Sep 16, 2021 | Sep 17, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 4,955 | $223k | 59.5% | Unusual | SEC |
| Sep 2, 2021 | Sep 3, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 10,000 | $400k | 54.6% | Unusual | SEC |
| Jul 14, 2021 | Jul 16, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 10,000 | $350k | 35.3% | Unusual | SEC |
| Mar 31, 2021 | Apr 2, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 10,000 | $300k | 26.1% | Unusual | SEC |
| Mar 15, 2021 | Mar 16, 2021 | BCYC | Chief Scientific Officer | Form 4 sale | 10,000 | $285k | 20.7% | Plan not stated | SEC |